In addition, all plans have to cover specific services, also known as essential coverage
Currently, the core registration studies to assess the efficacy of retatrutide include: TRIUMPH-1 : A randomized, double-blind, placebo-controlled trial to test the safety and effectiveness of a treatment for people with obesity or overweight, including those with OSA and OA, but without type 2 diabetes
Maintaining muscle mass is also a concern, with some studies showing a significant share of weight loss tied to lean mass
For injectable semaglutide (Ozempic, Wegovy) and other GLP-1 receptor agonists, taste disturbances are not specifically highlighted among the most common adverse effects, though gastrointestinal symptoms that might indirectly affect taste perception are well-documented
Research Use Only: Not for human or veterinary therapeutic applications
If youre considering retatrutide for weight loss, one of the first questions youre likely asking is: how long does retatrutide take to work